Galectin Therapeutics (GALT) Cash & Current Investments (2010 - 2026)
Galectin Therapeutics (GALT) reported Cash & Current Investments of $13.3 million for Q2 2026, down 3.4% from $13.77 million a year earlier and down 5.7% from the prior quarter.
Powered by 
Analysis
Galectin Therapeutics (GALT) Cash & Current Investments (2010 - 2026) Analysis & Trends
At the end of FY2025, Galectin Therapeutics posted Cash & Current Investments of $17.72 million, up 17.2% from FY2024.
- Cash & Current Investments has a five-year compound annual growth rate of -8.2% (FY2020 to FY2025).
- By year, Cash & Current Investments came in at $15.12 million in FY2024 (-41.1%), $25.66 million in FY2023 (+38.0%), $18.59 million in FY2022 (-53.1%) and $39.65 million in FY2021 (+46.1%).
- Five-year quarterly Cash & Current Investments spans a low of $7.43 million in Q1 2025 and a high of $39.65 million in Q4 2021.
- Year over year, Cash & Current Investments gained in three of the last eight quarters, with an average decline of 9.6%.
- The high point for year-over-year Cash & Current Investments in five years was Q1 2026 (growth of 89.9%); the low point was Q1 2025 (a decline of 68.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $14.11 million (Q1 2026), $17.72 million (Q4 2025) and $11.53 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Galectin Therapeutics | 210.80 Mn | 154.14 Mn | - | 13.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.30 Mn |
| Mar 31, 2026 | 14.11 Mn |
| Dec 31, 2025 | 17.72 Mn |
| Sep 30, 2025 | 11.53 Mn |
| Jun 30, 2025 | 13.77 Mn |
| Mar 31, 2025 | 7.43 Mn |
| Dec 31, 2024 | 15.12 Mn |
| Sep 30, 2024 | 27.06 Mn |
| Jun 30, 2024 | 25.60 Mn |
| Mar 31, 2024 | 23.56 Mn |
| Dec 31, 2023 | 25.66 Mn |
| Sep 30, 2023 | 20.36 Mn |
| Jun 30, 2023 | 17.97 Mn |
| Mar 31, 2023 | 17.80 Mn |
| Dec 31, 2022 | 18.59 Mn |
| Sep 30, 2022 | 15.83 Mn |
| Jun 30, 2022 | 24.18 Mn |
| Mar 31, 2022 | 31.61 Mn |
| Dec 31, 2021 | 39.65 Mn |
| Sep 30, 2021 | 36.60 Mn |
API Access
Galectin Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();